AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Telmisnov 40mg Tablet

Prescription Icon
Prescription Required

Marketer

Ausler Snovy Pharma

Salt Composition

Telmisartan (40mg)

Overview Telmisnov 40mg Tablet

Cardiovasc 40mg tablets manage hypertension and heart failure, reducing the risk of strokes and heart attacks. Beneficial in preserving renal function for diabetic patients, this medication can be administered alone or with other drugs, with or without food, at a consistent time daily for optimal effect. Continued use is crucial, even with controlled blood pressure, as symptoms may be absent despite the condition's persistence. Generally safe for long-term use, lifestyle modifications such as exercise, weight loss, smoking cessation, moderated alcohol consumption, and reduced dietary sodium, as directed by a physician, complement its efficacy. While well-tolerated, hypotension is a potential side effect; inform your doctor of any adverse reactions for dosage adjustment or alternative therapies. Prior to commencing treatment, disclose any kidney or liver issues, and pregnant or lactating individuals must consult their doctor. Regular monitoring of kidney function, blood pressure, and potassium levels may be undertaken during therapy.

Uses of Telmisnov 40mg Tablet

Managing high blood pressure | Cardiac insufficiency treatment | Pyrexia management | Cardiovascular event prophylaxis

Major Benefits of Telmisnov 40mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmisnov 40mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Telmisnov 40mg Tablet:

  • Diarrhea
  • Upper respiratory tract infection
  • Back pain
  • Sinus inflammation
  • Skin ulcer
  • Intermittent claudication

How to use Telmisnov 40mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 40mg Telmisnov tablet whole; do not break, crush, or chew it. While it can be taken with or without food, consistent timing is recommended.

How Telmisnov 40mg Tablet works:

Telmisartan 40mg tablets function as an angiotensin II receptor antagonist, widening blood vessels. This effect stems from its inhibition of a vasoconstricting substance, thus reducing blood pressure and improving blood flow to vital organs, enhancing cardiac efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Telmisartan 40mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Telmisartan 40mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in rare, life-threatening circumstances where the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the safety of Telmisartan 40mg tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a 40mg Telmisartan tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Telmisnov 40mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Disclosure of pre-existing kidney disease is vital. Routine monitoring of blood pressure, creatinine, and potassium levels during treatment is often recommended.

LiverLiverCAUTION

Patients with liver impairment should use Telmisnov 40mg tablets cautiously, potentially requiring a dosage modification. Physician consultation is advised. Telmisnov 40mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Telmisnov 40mg Tablet :

Omit any missed Telmisartan 40mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telmisnov 40mg Tablet

LabelValue
Type of Compound Benzimi dazole-based compound
Potential for Dependence None.
Type of Treatment Heart-related

FAQs on Telmisnov 40mg Tablet

A single 40mg Telmisartan tablet is typically prescribed for daily consumption, administered either in the morning or evening. Consistent daily timing aids medication adherence.
Noticeable improvement may occur within days, though optimal results are typically observed after four to eight weeks of therapy.
Discontinuing Telmisartan 40mg tablets without physician approval is inadvisable, regardless of blood pressure readings. Abrupt cessation can elevate blood pressure, posing potential health risks. Telmisartan 40mg tablets manage, not cure, hypertension; therefore, continuous use may be necessary. Consult your doctor with any questions or worries.
Consult your physician before using Telmisartan 40mg tablets. Regular monitoring of potassium and creatinine levels may be necessary to assess kidney function. Since Telmisartan 40mg tablets can potentially impair kidney function, immediately report any edema in the extremities or unexpected weight increase to your doctor.
Rest assured, Telmisnov 40mg tablets are not associated with weight increase. Animal research indicates that Telmisnov 40mg tablets may even reduce body fat.
Patients with diabetes taking Telmisartan 40mg tablets may experience a decrease in blood sugar. Consequently, consistent blood glucose monitoring is crucial. Diabetic patients should consult their physician, as their insulin or other diabetes medication dosage might require modification.
Telmisartan 40mg tablets may elevate blood potassium levels (hyperkalemia). Your physician might recommend routine potassium blood tests during treatment with this medication.
Telmisartan 40mg tablets do not induce increased urination and are not classified as diuretics. Their mechanism of action involves blood vessel dilation achieved by counteracting the effects of angiotensin II. Angiotensin II elevates blood pressure through vasoconstriction.
Concurrent use of ibuprofen and Telmisnov 40mg Tablets necessitates close monitoring of blood pressure and kidney function. Telmisnov 40mg Tablets can intensify ibuprofen's adverse effects, potentially leading to fluid retention, particularly in those using Telmisnov 40mg Tablets for heart failure. Ibuprofen might reduce the blood pressure-lowering efficacy of Telmisnov 40mg Tablets.
A single 40mg Telmisnov tablet is typically prescribed for daily use, administered either in the morning or evening. Maintaining a consistent daily intake time improves adherence to the prescribed regimen.
Noticeable effects may appear within days, though optimal results typically become evident within four to eight weeks of treatment commencement.
Refrain from discontinuing Telmisartan 40mg tablets without prior discussion with your physician, regardless of apparent blood pressure normalization. Abrupt cessation can elevate blood pressure, posing potential health risks. Telmisartan 40mg tablets manage, not cure, hypertension; therefore, continuous use may be necessary. Consult your doctor regarding any questions or worries.
Telmisartan 40mg tablets may elevate blood potassium levels (hyperkalemia). Your physician might recommend routine potassium blood tests during treatment with this medication.
Consult your physician before using Telmisartan 40mg tablets. Regular monitoring of kidney function, including potassium and creatinine levels, may be recommended by your doctor. Since Telmisartan 40mg tablets can potentially impair kidney function, immediately report any edema in the extremities (feet, ankles, or hands) or sudden weight increase to your doctor.
Concerns about weight gain with Telmisnov 40mg Tablet are unfounded. Animal research indicates this medication may even reduce body fat.
Patients with diabetes taking Telmisartan 40mg tablets may experience a decrease in blood sugar. Consequently, consistent blood glucose monitoring is vital. Diabetic patients should consult their physician as their insulin or other diabetes medications may require dosage modification.
Concurrent use of ibuprofen and Telmisnov 40mg Tablets necessitates close monitoring of blood pressure and kidney function. Telmisnov 40mg Tablets can intensify ibuprofen's adverse effects, potentially leading to fluid retention, particularly in patients using Telmisnov 40mg Tablets for congestive heart failure. Ibuprofen might reduce the hypotensive efficacy of Telmisnov 40mg Tablets.
Telmisartan 40mg tablets do not induce excessive urination; they are not diuretics. This medication lowers blood pressure by counteracting angiotensin II, a compound that constricts blood vessels and elevates blood pressure.
A single 40mg Telmisnov tablet is typically prescribed for daily use, administered either in the morning or evening. Consistent daily timing aids in medication adherence.
Noticeable improvements may appear within days, although optimal results typically become evident between four and eight weeks after treatment begins.
Never discontinue Telmisartan 40mg tablets without first discussing it with your physician, regardless of whether your blood pressure is currently under control. Abrupt cessation can lead to a potentially harmful rise in blood pressure. Telmisartan 40mg tablets manage, but do not cure, hypertension; therefore, continuous use may be necessary. Consult your doctor with any questions or worries.
Telmisartan 40mg tablets may elevate blood potassium levels (hyperkalemia). Your physician might recommend routine potassium level checks during treatment.
Use of Telmisartan 40mg tablets is permissible only under the guidance of a physician. Regular monitoring of kidney function, including potassium and creatinine levels, may be requested by your doctor. As Telmisartan 40mg tablets can potentially impair kidney function, immediately report any edema in the extremities (feet, ankles, or hands) or unexpected weight increase to your doctor.
There's no need for concern; Telmisnov 40mg Tablets are not associated with weight increase. Animal research indicates Telmisnov 40mg Tablets may even reduce body fat.
Patients with diabetes taking Telmisartan 40mg tablets may experience a reduction in blood glucose. Consequently, consistent monitoring of blood glucose is crucial. Diabetic patients should consult their physician as their insulin or other diabetes medication dosage might require modification.
Concurrent use of ibuprofen and Telmisnov 40mg Tablets necessitates close monitoring of blood pressure and kidney function. Telmisnov 40mg Tablets can intensify ibuprofen's adverse effects, potentially leading to fluid retention, particularly in patients using Telmisnov 40mg Tablets for congestive heart failure. Ibuprofen might reduce the blood pressure-lowering efficacy of Telmisnov 40mg Tablets.
Telmisartan 40mg tablets do not induce diuresis and are not diuretics. Their mechanism of action involves blood vessel dilation achieved by antagonizing angiotensin II, a vasoconstrictor that elevates blood pressure.
Telmisnov 40mg Tablet
44
MRP 53
16% off